mhurhangee/patent-ind-claim-en huggingface dataset:
A recombinant host cell, comprising a recombinant gene encoding a polypeptide catalyzing glycosylation of steviol, steviol-1,2-bioside, steviol-1,3-bioside, steviol-13- O -glucoside (13-SMG), and/or Rebaudioside B (RebB) at its C-19 carboxyl group and having at least 80% sequence identity to the amino acid sequence set forth in SEQ ID NO:2 or 119, wherein the recombinant host cell is producing a steviol glycoside or a steviol glycoside composition.
A FlexRay network bus guardian comprising: a resetting leading coldstart node, RLCN, detector configured to detect a RLCN failure; a deaf coldstart node, DCN, detector configured to detect a DCN failure; a babbling idiot, BI, detector configured to detect a BI failure; and a FlexRay network decoder configured to output a signal regarding the status of the FlexRay network to the RLCN detector, DCN detector, and BI detector, wherein the RLCN detector, DCN detector, and BI detector are configured to send an indication of a failure to a containment module if a failure has been detected, and the containment module is configured to disable one of a single node and a network branch in the FlexRay network. a resetting leading coldstart node, RLCN, detector configured to detect a RLCN failure; a deaf coldstart node, DCN, detector configured to detect a DCN failure; a babbling idiot, BI, detector configured to detect a BI failure; and a FlexRay network decoder configured to output a signal regarding the status of the FlexRay network to the RLCN detector, DCN detector, and BI detector, wherein the RLCN detector, DCN detector, and BI detector are configured to send an indication of a failure to a containment module if a failure has been detected, and the containment module is configured to disable one of a single node and a network branch in the FlexRay network.
Fuel tank comprising a fuel container with a connection part of the fuel container, a filler tube and a connector for connecting the filler tube to the connection part of the fuel container, the connector being a substantially cylindrical sheet metal moulded part with a first connecting end which is fastened to the filler tube and with a male second connecting end which is received in the connection part of the fuel container, a first groove being formed into the sheet metal moulded part in a first section of the second connecting end , an annular locking element reaching at least in sections through openings of the connection part of the fuel container into the interior of the connection part of the fuel container and securing the connection part of the fuel container there axially with respect to the connector by way of a support, in particular a positively locking connection, on the first groove of the connector , a ramp ring being arranged in a third section of the second connecting end , the ramp ring being a peripheral component with a wedge-shaped ramp face, a conical section of the connection part of the fuel container bearing on the outside against the wedge-shaped ramp face of the ramp ring , the locking element being supported on the ramp ring as an intermediate component, the ramp ring being secured axially in or on the first groove .
A delayed-release pharmaceutical composition for biguanide compound delivery, comprising an oral dosage form having a core comprising a therapeutically effective amount of a biguanide compound and an enteric coating surrounding said core that delays release of said biguanide compound after ingestion until reaching the distal small intestine, wherein said oral dosage form is an enterically-coated tablet or capsule, wherein said enteric coating is applied to said oral dosage form to about 3% to about a 6% (wt/wt) weight gain, and wherein less than 15% of the biguanide compound is released after the composition contacts an aqueous medium of 0.1 N HCI for two hours and is subsequently transferred to an aqueous medium at a pH of about 6.8 for a lag phase of at least ten minutes, and at least 60% of the biguanide compound is released after the lag phase and within 60 minutes at pH 6.8, and at least 90% of the biguanide compound is released within 90 to 120 minutes at pH 6.8, measured in an USP Type II apparatus in a medium at 37°C
A horological movement comprising: - A plate ; - A mechanical resonator comprising: • An oscillating balance rotatably mounted relative to the plate about an axis , this balance having an upper face and a lower face , and • A spiral spring coupled to the balance , this spiral spring having a first end fixed relative to the plate and a second end secured to the balance ; - An electromagnetic regulator coupled to the mechanical resonator to regulate the frequency of the balance oscillations, this electromagnetic regulator comprising: • At least one permanent magnet , • At least one coil , • A quartz or silicon resonator and • An electronic circuit connected to the resonator and to the coil ; This movement being characterised in that : - The magnet is fixedly mounted relative to the plate ; - The coil , the resonator and the electronic circuit are mounted on the balance while being completely included in at least one inner cavity delimited by the latter. - A plate ; - A mechanical resonator comprising: • An oscillating balance rotatably mounted relative to the plate about an axis , this balance having an upper face and a lower face , and • A spiral spring coupled to the balance , this spiral spring having a first end fixed relative to the plate and a second end secured to the balance ; • An oscillating balance rotatably mounted relative to the plate about an axis , this balance having an upper face and a lower face , and • A spiral spring coupled to the balance , this spiral spring having a first end fixed relative to the plate and a second end secured to the balance ; - An electromagnetic regulator coupled to the mechanical resonator to regulate the frequency of the balance oscillations, this electromagnetic regulator comprising: • At least one permanent magnet , • At least one coil , • A quartz or silicon resonator and • An electronic circuit connected to the resonator and to the coil ; • At least one permanent magnet , • At least one coil , • A quartz or silicon resonator and • An electronic circuit connected to the resonator and to the coil ; - The magnet is fixedly mounted relative to the plate ; - The coil , the resonator and the electronic circuit are mounted on the balance while being completely included in at least one inner cavity delimited by the latter.
A method for wireless communication at a user equipment, UE, the method comprising: selecting , for each of a plurality of periodic search opportunities, one receive beam of a plurality of receive beams for receiving at least one synchronization signal, the plurality of periodic search opportunities comprising a plurality of regular search opportunities and a plurality of prioritized search opportunities, the plurality of receive beams comprising at least one prioritized receive beam and at least one additional receive beam, the selecting for each of the plurality of periodic search opportunities comprising: selecting from the at least one prioritized receive beam for each of the plurality of prioritized search opportunities; and selecting from the plurality of receive beams for each of the plurality of regular search opportunities; and receiving , at each of the plurality of periodic search opportunities, the corresponding at least one synchronization signal using the corresponding selected receive beam. selecting from the at least one prioritized receive beam for each of the plurality of prioritized search opportunities; and selecting from the plurality of receive beams for each of the plurality of regular search opportunities; and receiving , at each of the plurality of periodic search opportunities, the corresponding at least one synchronization signal using the corresponding selected receive beam.
An agrochemical concentrate comprising; i) at least one structurant, said structurant being a polyol ester of a C 4 to C 16 dicarboxylic acid, and where the amount of structurant present is in the range 0.1 wt.% to 12.0 wt.%; ii) surfactant adjuvant; iii) at least one agrochemical active selected from insecticides, fungicides, or herbicides and/or nutrient; and wherein the surfactant adjuvant is selected from polyoxyethylene C12-C15 alcohol C8-C10 alkylpolysaccharide, polyoxyethylene castor oil, polyoxyethylene di-ethyl ethanol amine mono-trimerate, polyoxyethylene sorbitol oleate, or polyoxyethylene sorbitan mono laurate, wherein the surfactant adjuvant concentration is greater than about 50 wt.% of the total concentrate, and wherein the concentrate is formulated as a suspension concentrate (SC), oil-based suspension concentrate (OD), or suspoemulsions (SE) formulation; wherein the structurant is obtainable by the reaction of; C 4 to C 16 dicarboxylic acid; sorbitol or sorbitan; and C 16 to C 30 monocarboxylic fatty acid, wherein the molar ratio of C 4 to C 16 dicarboxylic acid, sorbitol or sorbitan, and C 16 to C 30 monocarboxylic fatty acid present in the structurant is in the range from 0.5-1.5:1.5-2.5:2.5-3.5 respectively. i) at least one structurant, said structurant being a polyol ester of a C 4 to C 16 dicarboxylic acid, and where the amount of structurant present is in the range 0.1 wt.% to 12.0 wt.%; ii) surfactant adjuvant; iii) at least one agrochemical active selected from insecticides, fungicides, or herbicides and/or nutrient; and
Infusible three-dimensional network of crosslinked acrylic-type polymer fibres, characterized in that : - the diameter of said fibres is comprised between 0.1 and 1.5 μm, preferably between 0.3 and 1 μm, and more preferentially between 0.6 and 0.8 μm, - the size of the interstices between said fibres is comprised between 0.1 and 50 μm 2 , preferably between 0.5 and 10 μm 2 , and more preferentially between 1 and 2 μm 2 , and - the stiffness of said network is characterized by an elastic modulus comprised between 0.01 and 10,000 kPa, preferably between 0.1 and 10,000 kPa, preferably between 0.1 and 1,000 kPa, more preferentially between 0.1 and 300 kPa. - the diameter of said fibres is comprised between 0.1 and 1.5 μm, preferably between 0.3 and 1 μm, and more preferentially between 0.6 and 0.8 μm, - the size of the interstices between said fibres is comprised between 0.1 and 50 μm 2 , preferably between 0.5 and 10 μm 2 , and more preferentially between 1 and 2 μm 2 , and - the stiffness of said network is characterized by an elastic modulus comprised between 0.01 and 10,000 kPa, preferably between 0.1 and 10,000 kPa, preferably between 0.1 and 1,000 kPa, more preferentially between 0.1 and 300 kPa.
An rAAV for use in a method of treating an ocular disease, the method comprising: administering to ocular tissue of a subject an effective amount of the rAAV, wherein the rAAV comprises: (i) a capsid protein having a serotype selected from the group consisting of AAV6, AAV6.2, AAV7, AAV8, AAV9, AAVrh.8, AAVrh.10, AAVrh.39, and AAVrh.43, and (ii) a nucleic acid comprising a promoter operably linked to a transgene, wherein the transgene comprises a region of complementarity to SEQ ID NO:1, and wherein the transgene decreases the expression of miR-21 wherein the ocular disease is associated with the up-regulation of miR-21. (i) a capsid protein having a serotype selected from the group consisting of AAV6, AAV6.2, AAV7, AAV8, AAV9, AAVrh.8, AAVrh.10, AAVrh.39, and AAVrh.43, and (ii) a nucleic acid comprising a promoter operably linked to a transgene, wherein the transgene comprises a region of complementarity to SEQ ID NO:1, and wherein the transgene decreases the expression of miR-21
A reactor for block polymerization of monomers to form a polymer block, comprising: - a main chamber for forming a polymer block therein, wherein the main chamber is limited by: - a main body having a bottom and two longitudinal walls; - two end walls detachably mounted to the main body ; and - a longitudinal cover detachably mounted to the main body ; characterized in that the reactor further comprises a longitudinal frame mounted outside the main body and configured to keep the reactor in its assembled form during the polymerization, wherein the main body and the end walls are made of poly(tetrafluoroethylene) (PTFE), and wherein the end walls and the longitudinal cover are configured to be detached from the main chamber to remove the polymer block from the main chamber after the polymerization. - a main chamber for forming a polymer block therein, wherein the main chamber is limited by: - a main body having a bottom and two longitudinal walls; - two end walls detachably mounted to the main body ; and - a longitudinal cover detachably mounted to the main body ; - a main body having a bottom and two longitudinal walls; - two end walls detachably mounted to the main body ; and - a longitudinal cover detachably mounted to the main body ;
An imaging system for imaging of subjects, the imaging system comprising: a spectral camera configured to capture a spectral image of a subject in a spectral capture period comprising a plurality of spectral time points, the spectral image comprising a plurality of spectral frames each captured at a wavelength of a plurality of wavelengths and each corresponding to a spectral time point of the plurality of spectral time points; a reference camera configured to capture a reference image of the subject in a reference capture period comprising a plurality of reference time points and corresponding to the spectral capture period, the reference image comprising a plurality of reference frames each corresponding to a reference time point of the plurality of reference time points and a spectral frame of the plurality of spectral frames; characterised by : a calculation unit configured to calculate a motion vector for each reference frame of a subset of the plurality of reference frames; and an alignment unit configured to align the spectral frames with each other by applying each calculated motion vector to the spectral frame of the plurality of spectral frames to which it corresponds. a spectral camera configured to capture a spectral image of a subject in a spectral capture period comprising a plurality of spectral time points, the spectral image comprising a plurality of spectral frames each captured at a wavelength of a plurality of wavelengths and each corresponding to a spectral time point of the plurality of spectral time points; a reference camera configured to capture a reference image of the subject in a reference capture period comprising a plurality of reference time points and corresponding to the spectral capture period, the reference image comprising a plurality of reference frames each corresponding to a reference time point of the plurality of reference time points and a spectral frame of the plurality of spectral frames; a calculation unit configured to calculate a motion vector for each reference frame of a subset of the plurality of reference frames; and an alignment unit configured to align the spectral frames with each other by applying each calculated motion vector to the spectral frame of the plurality of spectral frames to which it corresponds.
An aqueous inkjet ink for textile printing comprising a disperse dyestuff, a dispersant and a glycerol ester of two or three carboxylic acids with a hydrocarbon chain having at least 8 carbon atoms.
A liquid, inanimate surface treatment composition which imparts a microbicidal benefit to treated surfaces which composition consists essentially of: a zinc ion source material which releases zinc ions into the treatment composition, preferably a source of Zn ++ ions; at least 35% wt up to but less than 45wt% of at least one C 1 - C 3 monohydric aliphatic alcohol; water; at least one detersive surfactant, other than a cationic quaternary ammonium compound; and a buffer or pH adjusting agent to impart an alkaline pH; wherein the composition has a pH of 9 to 11.5; wherein the surface treatment compositions are characterized in exhibiting a 2 log 10 reduction against poliovirus type 1 (Sabin) ("PV1"), when tested according to one or more of the following standardized test protocols: ASTM E1052 Standard Test Method for Efficacy of Antimicrobial Agents against Viruses in Suspension, or ASTM E1053 Standard Test Method to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental Surfaces. a zinc ion source material which releases zinc ions into the treatment composition, preferably a source of Zn ++ ions; at least 35% wt up to but less than 45wt% of at least one C 1 - C 3 monohydric aliphatic alcohol; water; at least one detersive surfactant, other than a cationic quaternary ammonium compound; and a buffer or pH adjusting agent to impart an alkaline pH; wherein the composition has a pH of 9 to 11.5; wherein the surface treatment compositions are characterized in exhibiting a 2 log 10 reduction against poliovirus type 1 (Sabin) ("PV1"), when tested according to one or more of the following standardized test protocols: ASTM E1052 Standard Test Method for Efficacy of Antimicrobial Agents against Viruses in Suspension, or ASTM E1053 Standard Test Method to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental Surfaces.
A method comprising: receiving, by one or more processors, audio panning data, the audio panning data including a first grid specifying first speaker gains of first virtual sound sources in a space, the first speaker gains correspond to one or more speakers in the space; the method is characterized by determining a second grid of second virtual sound sources in the space based on the first grid , including mapping the first speaker gains into second speaker gains of the second virtual sound sources , wherein the second virtual sound sources are fewer than the first virtual sound sources ; selecting, based on a size parameter of an audio object , at least one of the first grid or second grid for rendering an audio object ; and rendering the audio object based on the selected grid or grids, including representing the audio object using one or more virtual sound sources in each selected grid that are enclosed in a sound space defined at least in part by the size parameter. receiving, by one or more processors, audio panning data, the audio panning data including a first grid specifying first speaker gains of first virtual sound sources in a space, the first speaker gains correspond to one or more speakers in the space; the method is characterized by determining a second grid of second virtual sound sources in the space based on the first grid , including mapping the first speaker gains into second speaker gains of the second virtual sound sources , wherein the second virtual sound sources are fewer than the first virtual sound sources ; selecting, based on a size parameter of an audio object , at least one of the first grid or second grid for rendering an audio object ; and rendering the audio object based on the selected grid or grids, including representing the audio object using one or more virtual sound sources in each selected grid that are enclosed in a sound space defined at least in part by the size parameter.
A method of treatment of bauxite residue resulting from a Bayer process of bauxite treatment in order to produce a solid product, the method comprising: mixing a quantity of the bauxite residue with a quantity of a glass material and a quantity of fines to form a mixture; compressing the mixture to form a green body; sintering the green body; and, cooling the sintered green body thereby to produce the solid product; characterised in that the fines are a result of crushing a said solid product. mixing a quantity of the bauxite residue with a quantity of a glass material and a quantity of fines to form a mixture; compressing the mixture to form a green body; sintering the green body; and, cooling the sintered green body thereby to produce the solid product; characterised in that the fines are a result of crushing a said solid product.
Secondary electrochemical generator with zinc electrode, characterised in that it comprises a) an electrolyte which is an alkaline aqueous solution with a molarity of between 4 M and 15 M of hydroxyl anions, comprising soluble silicates whose concentration expressed as silica (SiO 2 ) is between 0.15 g/l and 80 g/l; and b) a zinc electrode containing a conductive ceramic at least partly consisting of hafnium nitride and/or carbide and/or magnesium carbide and/or nitride and/or silicide and/or niobium carbide and/or nitride and/or titanium carbide and/or nitride and/or silicide and/or vanadium nitride and/or double carbides and/or nitrides of any two metals selected from hafnium, magnesium, niobium, titanium and vanadium. a) an electrolyte which is an alkaline aqueous solution with a molarity of between 4 M and 15 M of hydroxyl anions, comprising soluble silicates whose concentration expressed as silica (SiO 2 ) is between 0.15 g/l and 80 g/l; and b) a zinc electrode containing a conductive ceramic at least partly consisting of hafnium nitride and/or carbide and/or magnesium carbide and/or nitride and/or silicide and/or niobium carbide and/or nitride and/or titanium carbide and/or nitride and/or silicide and/or vanadium nitride and/or
Wheelchair comprising a first and a second traction wheel and a traction device having a freewheel , a recovery pulley angularly connected to the traction wheels via the freewheel , a tension flexible element manually operable via a handle by a user sitting on the wheelchair and connected to the recovery pulley to provide a traction torque to the traction wheels when tensioned by the user, a recovery angular spring (M) acting on the recovery pulley to wind the released flexible element along a variable working angle about the recovery pulley , characterised by a module having said recovery pulley , said freewheel , an attaching element for rigidly connecting the module to a frame of the wheelchair and an interface unit for rigidly connecting said freewheel to at least one of the said traction wheels .
An aspirator, comprising: an aspirator body defining an air channel ; and an aspirator barrel having a first aspirator barrel segment coupled to the aspirator body and having a second aspirator barrel segment , the second aspirator barrel segment configured to fit at least partially within the first aspirator barrel segment when the aspirator barrel is in a stowed state and configured to interlock with the first aspirator barrel segment in an extended position when the aspirator barrel is in a deployed state; further comprising a liner coupled to the aspirator to form a seal between the first aspirator barrel segment and the second aspirator barrel segment; and characterized by a third aspirator barrel segment, said third aspirator barrel segment configured to fit at least partially within the second aspirator barrel segment when the aspirator barrel is in the stowed state. an aspirator body defining an air channel ; and an aspirator barrel having a first aspirator barrel segment coupled to the aspirator body and having a second aspirator barrel segment , the second aspirator barrel segment configured to fit at least partially within the first aspirator barrel segment when the aspirator barrel is in a stowed state and configured to interlock with the first aspirator barrel segment in an extended position when the aspirator barrel is in a deployed state; further comprising a liner coupled to the aspirator to form a seal between the first aspirator barrel segment and the second aspirator barrel segment; and characterized by a third aspirator barrel segment, said third aspirator barrel segment configured to fit at least partially within the second aspirator barrel segment when the aspirator barrel is in the stowed state.